We are live on
!
Find out more
Macquarie Group Portfolio holdings
AUM
$16.8B
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter
Est. Return
+10.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$84.7B
AUM Growth
+$3.15B
(+3.9%)
Cap. Flow
-$3.2B
Cap. Flow
% of AUM
-3.77%
Top 10 Holdings %
Top 10 Hldgs %
10.93%
Holding
2,264
New
35
Increased
617
Reduced
853
Closed
525
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
L3Harris
LHX
|
+$128M |
| 2 |
Danaher
DHR
|
+$114M |
| 3 |
Zebra Technologies
ZBRA
|
+$112M |
| 4 |
Assurant
AIZ
|
+$92.7M |
| 5 |
Exelon
EXC
|
+$92.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$189M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$143M |
| 3 |
Merck
MRK
|
+$136M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$124M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Healthcare | 15.17% |
| 3 | Financials | 13.51% |
| 4 | Industrials | 10.72% |
| 5 | Consumer Discretionary | 9.33% |
Similar funds
AIMCA
CI
BCIM
VMPIC
EIP
DADC
PP
ASRS
Macquarie Group's Q4 2022 Portfolio in Review
As of Q4 2022, Macquarie Group held 2,264 positions worth $84.7B, up 3.9% from $81.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Macquarie Group withdrew a net $3.2B in Q4 2022, closing 525 positions and reducing 853 holdings. Its most notable exit was Abiomed Inc, an estimated $124M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Macquarie Group opened a new position in iShares 0-5 Year Investment Grade Corporate Bond ETF worth $58.3M.
- Macquarie Group's largest Q4 2022 buy was iShares 0-5 Year Investment Grade Corporate Bond ETF: 1,218,670 shares worth $58.3M.
- Macquarie Group added most to L3Harris in Q4 2022, an estimated $128M increase.
- Macquarie Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $189M.
- Macquarie Group fully exited Abiomed Inc in Q4 2022, selling an estimated $124M.
- Macquarie Group's ten largest holdings make up 11% of its $84.7B portfolio in Q4 2022.
- Macquarie Group opened 35 new positions and closed 525 in Q4 2022.
- Macquarie Group's portfolio value rose 3.9% quarter-over-quarter to $84.7B.
Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.